FRAXA's mission is to accelerate progress toward effective treatments and a cure for Fragile X, by funding the most promising research.
FRAXA's goal is to cure Fragile X:
Results of first trial of fenobam in adults with Fragile X published in major journal!
National Public Radio (NPR)
Drugs Hint At Potential
Reversal Of Autism
Find links to this amazing story and lots more news at:
1. Fragile X is the most common inherited cause of mental impairment and the most common known cause of autism.
2. Research is yielding some extremely positive results in clinical trials that may reverse forms of autism!
Fraxa Research Foundation, Inc.
a 501(c)(3) nonprofit (EIN: 04-3222167)